Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 29, 2026

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
09:58

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing

Published on: April 23, 2015

Spheroid-based drug screen: considerations and practical approach.

Juergen Friedrich1, Claudia Seidel, Reinhard Ebner

  • 1OncoRay-Center for Radiation Research in Oncology, Tumor Pathophysiology, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, Germany.

Nature Protocols
|February 14, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extract of <i>Indigofera spicata</i> Exerts Antiproliferative Effects on Human Colorectal and Ovarian Carcinoma Cells.

Toxins·2025
Same author

Adaptation to Arginine Deprivation Leads to a More Aggressive, Therapy-Resistant Phenotype in HNSCC Cells.

Biomolecules·2025
Same author

Image segmentation of treated and untreated tumor spheroids by fully convolutional networks.

GigaScience·2025
Same author

The Spheroid Light Microscopy Image Atlas for morphometrical analysis of three-dimensional cell cultures.

Scientific data·2025
Same author

Generalized, sublethal damage-based mathematical approach for improved modeling of clonogenic survival curve flattening upon hyperthermia, radiotherapy, and beyond.

Physics in medicine and biology·2025
Same author

Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.

NPJ precision oncology·2024
Same journal

iMUT-seq mapping of DSB-induced mutations with high sensitivity at single-nucleotide resolution.

Nature protocols·2026
Same journal

An assay to quantify sexual commitment and stage conversion in the human malaria parasite Plasmodium falciparum.

Nature protocols·2026
Same journal

Author Correction: Direct inoculation of bioreactor-controlled stirred suspension culture with cryopreserved human pluripotent stem cells.

Nature protocols·2026
Same journal

High-throughput measurements of protein domain functions using magnetic separation.

Nature protocols·2026
Same journal

Inducing physiological polarity and performing gene editing using CRISPR-Cas9 in human trophoblast organoids.

Nature protocols·2026
Same journal

Photocatalytic low-temperature defluorination of PTFE.

Nature protocols·2026
See all related articles

Three-dimensional (3D) multicellular spheroids offer a reproducible and cost-effective method for drug screening. This standardized protocol enhances the predictive power of 3D culture models in drug development.

Area of Science:

  • Biotechnology
  • Drug Discovery
  • Cancer Research

Background:

  • Three-dimensional (3D) culture models, while used in research for decades, were previously considered impractical for drug development.
  • Advances in technology and gene expression similarities to clinical profiles have renewed interest in 3D models for predicting drug efficacy.
  • 3D culture systems better mimic human tumor tissue pathophysiology compared to traditional 2D cultures.

Purpose of the Study:

  • To describe a standardized, easy-to-handle setup for culturing, treating, and analyzing multicellular spheroids.
  • To provide practical considerations for establishing and utilizing spheroid-based drug screening platforms.
  • To identify human carcinoma cell lines suitable for reproducible spheroid formation under identical conditions.

Main Methods:

More Related Videos

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
10:38

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Published on: December 16, 2022

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

Related Experiment Videos

Last Updated: May 29, 2026

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
09:58

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing

Published on: April 23, 2015

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
10:38

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Published on: December 16, 2022

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

  • Development of a standardized protocol for reproducible multicellular spheroid culture and analysis.
  • Utilized a list of human carcinoma cell lines, including some from the NCI-DTP 60-cell line screen.
  • Assessed spheroid integrity and cell survival via acid phosphatase assay; monitored growth kinetics for drug treatment effects.

Main Results:

  • The described protocol enables reproducible, easy-handling culture and analysis of multicellular spheroids.
  • The method is suitable for integration into standardized, large-scale drug testing routines, requiring minimal spheroids and drug.
  • The complete screening protocol, including analysis, takes approximately 170 hours; long-term culturing is needed for growth kinetics analysis.

Conclusions:

  • Standardized spheroid culture provides a feasible and powerful platform for drug development, improving prediction of clinical efficacy.
  • This protocol facilitates efficient, large-scale drug screening with enhanced reproducibility and reduced resource requirements.
  • Spheroid-based drug screening offers a more clinically relevant model for evaluating therapeutic potential.